Literature DB >> 22493754

Classification of exon 18 linked variants of VWF gene in von Willebrand disease.

Shirin Shahbazi1, Sara Alavi, Reza Mahdian.   

Abstract

Defects in von Willebrand factor, a crucial protein in haemostasis, lead to the most common inherited coagulopathy in man, von Willebrand disease. To date, over 350 mutations and 170 single nucleotide polymorphisms of VWF gene have been reported. In the present study, the distribution of two linked VWF gene variants, rs1063856 and rs1063857 have been assessed. The proportional frequency of rs1063856 (2365A/G) and rs1063857 (2385T/C) in healthy individuals were 0.70/0.30. Frequency of polymorphisms was in agreement with predicted geographical distribution. von Willebrand disease was more common in subjects with 2365A and 2385T alleles (odds ratio=1.35), although the difference was not statistically significant (p-values>0.05). The perfect correlation between these two single nucleotide polymorphisms supports their joint contribution in von Willebrand factor biology.

Entities:  

Keywords:  VWF gene; allele frequency; genetic polymorphisms; von Willebrand disease

Year:  2012        PMID: 22493754      PMCID: PMC3316446     

Source DB:  PubMed          Journal:  Int J Mol Epidemiol Genet        ISSN: 1948-1756


  27 in total

1.  Genetic variation associated with plasma von Willebrand factor levels and the risk of incident venous thrombosis.

Authors:  Nicholas L Smith; Kenneth M Rice; Edwin G Bovill; Mary Cushman; Joshua C Bis; Barbara McKnight; Thomas Lumley; Nicole L Glazer; Astrid van Hylckama Vlieg; Weihong Tang; Abbas Dehghan; David P Strachan; Christopher J O'Donnell; Jerome I Rotter; Susan R Heckbert; Bruce M Psaty; Frits R Rosendaal
Journal:  Blood       Date:  2010-12-16       Impact factor: 22.113

2.  Impact of the Thr789Ala variant of the von Willebrand factor levels, on ristocetin co-factor and collagen binding capacity and its association with coronary heart disease in patients with diabetes mellitus type 2.

Authors:  T Klemm; A K Mehnert; A Siegemund; T D Wiesner; G Gelbrich; M Blüher; R Paschke
Journal:  Exp Clin Endocrinol Diabetes       Date:  2005-12       Impact factor: 2.949

3.  Genetic determinants of plasma von Willebrand factor antigen levels: a target gene SNP and haplotype analysis of ARIC cohort.

Authors:  Marco Campos; Wei Sun; Fuli Yu; Maja Barbalic; Weihong Tang; Lloyd E Chambless; Kenneth K Wu; Christie Ballantyne; Aaron R Folsom; Eric Boerwinkle; Jing-Fei Dong
Journal:  Blood       Date:  2011-02-22       Impact factor: 22.113

Review 4.  Constitutive and regulated secretion of proteins.

Authors:  T L Burgess; R B Kelly
Journal:  Annu Rev Cell Biol       Date:  1987

5.  Variation in the von Willebrand factor gene is associated with von Willebrand factor levels and with the risk for cardiovascular disease.

Authors:  Marianne C van Schie; Moniek P M de Maat; Aaron Isaacs; Cornelia M van Duijn; Jaap W Deckers; Diederik W J Dippel; Frank W G Leebeek
Journal:  Blood       Date:  2010-10-12       Impact factor: 22.113

6.  Impact of 789Ala/Ala genotype on quantitative type of von Willebrand disease.

Authors:  Firdos Ahmad; Meganathan Kannan; Arijit Biswas; Renu Saxena
Journal:  Ann Hematol       Date:  2008-10-16       Impact factor: 3.673

7.  Human von Willebrand factor (vWF): isolation of complementary DNA (cDNA) clones and chromosomal localization.

Authors:  D Ginsburg; R I Handin; D T Bonthron; T A Donlon; G A Bruns; S A Latt; S H Orkin
Journal:  Science       Date:  1985-06-21       Impact factor: 47.728

8.  Divergent fates of von Willebrand factor and its propolypeptide (von Willebrand antigen II) after secretion from endothelial cells.

Authors:  D D Wagner; P J Fay; L A Sporn; S Sinha; S O Lawrence; V J Marder
Journal:  Proc Natl Acad Sci U S A       Date:  1987-04       Impact factor: 11.205

9.  RsaI polymorphism in von Willebrand factor (vWF) at codon 789.

Authors:  G R Kunkel; J B Graham; D M Fowlkes; S T Lord
Journal:  Nucleic Acids Res       Date:  1990-08-25       Impact factor: 16.971

10.  Novel associations of multiple genetic loci with plasma levels of factor VII, factor VIII, and von Willebrand factor: The CHARGE (Cohorts for Heart and Aging Research in Genome Epidemiology) Consortium.

Authors:  Nicholas L Smith; Ming-Huei Chen; Abbas Dehghan; David P Strachan; Saonli Basu; Nicole Soranzo; Caroline Hayward; Igor Rudan; Maria Sabater-Lleal; Joshua C Bis; Moniek P M de Maat; Ann Rumley; Xiaoxiao Kong; Qiong Yang; Frances M K Williams; Veronique Vitart; Harry Campbell; Anders Mälarstig; Kerri L Wiggins; Cornelia M Van Duijn; Wendy L McArdle; James S Pankow; Andrew D Johnson; Angela Silveira; Barbara McKnight; Andre G Uitterlinden; Nena Aleksic; James B Meigs; Annette Peters; Wolfgang Koenig; Mary Cushman; Sekar Kathiresan; Jerome I Rotter; Edwin G Bovill; Albert Hofman; Eric Boerwinkle; Geoffrey H Tofler; John F Peden; Bruce M Psaty; Frank Leebeek; Aaron R Folsom; Martin G Larson; Timothy D Spector; Alan F Wright; James F Wilson; Anders Hamsten; Thomas Lumley; Jacqueline C M Witteman; Weihong Tang; Christopher J O'Donnell
Journal:  Circulation       Date:  2010-03-15       Impact factor: 29.690

View more
  3 in total

1.  Common and rare von Willebrand factor (VWF) coding variants, VWF levels, and factor VIII levels in African Americans: the NHLBI Exome Sequencing Project.

Authors:  Jill M Johnsen; Paul L Auer; Alanna C Morrison; Shuo Jiao; Peng Wei; Jeffrey Haessler; Keolu Fox; Sean R McGee; Joshua D Smith; Christopher S Carlson; Nicholas Smith; Eric Boerwinkle; Charles Kooperberg; Deborah A Nickerson; Stephen S Rich; David Green; Ulrike Peters; Mary Cushman; Alex P Reiner
Journal:  Blood       Date:  2013-05-20       Impact factor: 22.113

2.  Combined genetic effects of EGLN1 and VWF modulate thrombotic outcome in hypoxia revealed by Ayurgenomics approach.

Authors:  Shilpi Aggarwal; Atish Gheware; Anurag Agrawal; Saurabh Ghosh; Bhavana Prasher; Mitali Mukerji
Journal:  J Transl Med       Date:  2015-06-06       Impact factor: 5.531

Review 3.  Nonsense-mediated mRNA decay among coagulation factor genes.

Authors:  Shirin Shahbazi
Journal:  Iran J Basic Med Sci       Date:  2016-04       Impact factor: 2.699

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.